Cohort | Dulaglutide, n = 30 | Liraglutide, n = 30 | ||||||
---|---|---|---|---|---|---|---|---|
Parameter | Baseline Mean ± SEM | Follow-up Mean ± SEM | Change Mean ± SEM | P | Baseline Mean ± SEM | Follow-up Mean ± SEM | Change Mean ± SEM | P |
Body weight (kg) | 87.17 ± 2.16 | 82.97 ± 2.05 | −4.20 ± 0.47 | < 0.001 | 89.43 ± 2.60 | 83.60 ± 2.35 | −5.83 ± 0.87 | < 0.001 |
BMI (kg/m2) | 32.84 ± 0.77 | 31.312 ± 0 .68 | −1.53 ± 0.21 | < 0.001 | 34.92 ± 0.868 | 32.650 ± 0.77 | −2.27 ± 0.33 | < 0.001 |
SBP (mmHg) | 134.30 ± 2.71 | 130.87 ± 2.49 | −3.43 ± 2.97 | 0.258 | 137.83 ± 2.503 | 127.60 ± 2.07 | −10.23 ± 2.36 | < 0.001 |
DBP (mmHg) | 80.73 ± 1.64 | 78.43 ± 0.914 | − 2.30 ± 1.79 | 0.208 | 83.47 ± 1.587 | 80.67 ± 1.51 | − 2.80 ± 1.85 | 0.141 |
FPG(mg/dl) | 175.53 ± 11.45 | 133.67 ± 6.90 | − 41.87 ± 12.72 | 0.003 | 160.13 ± 8.17 | 115.93 ± 5.69 | − 44.20 ± 8.05 | < 0.001 |
HbA1c (%) | 8.43 ± 0.21 | 7.411 ± 0.15 | −1.017 ± 0.22 | < 0.001 | 8.49 ± 0.26 | 6.95 ± 0.21 | − 1.547 ± 0.22 | < 0.001 |